|
Volumn 17, Issue 5, 2011, Pages 707-716
|
Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin
b
Roche
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALPHA GLUCOSIDASE INHIBITOR;
EXENDIN 4;
GLUCAGON LIKE PEPTIDE;
GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST;
HEMOGLOBIN A1C;
INSULIN;
MEGLITINIDE;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
SULFONYLUREA;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BODY MASS;
BODY WEIGHT;
COHORT ANALYSIS;
COMORBIDITY;
DEMOGRAPHY;
DRUG UTILIZATION;
FEMALE;
GLYCEMIC CONTROL;
GROUPS BY AGE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PRESCRIPTION;
RETROSPECTIVE STUDY;
SEX DIFFERENCE;
SIDE EFFECT;
UNITED STATES;
WEIGHT GAIN;
ADOLESCENT;
ADULT;
BLOOD GLUCOSE;
BLOOD PRESSURE;
BODY MASS INDEX;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MALE;
MIDDLE AGED;
PEPTIDES;
PROPORTIONAL HAZARDS MODELS;
RECEPTORS, GLUCAGON;
RETROSPECTIVE STUDIES;
VENOMS;
YOUNG ADULT;
|
EID: 80054081614
PISSN: 1530891X
EISSN: 19342403
Source Type: Journal
DOI: 10.4158/EP11014.OR Document Type: Article |
Times cited : (11)
|
References (15)
|